Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
02/2013
02/13/2013CN102933564A 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
02/13/2013CN102924398A Method for removing efavirenz corresponding isomers
02/12/2013US8372833 Urea derivative
02/12/2013CA2542941C Analysis of mass spectral data in the quiet zones and label selection therefor
02/12/2013CA2539059C Novel ligand activating receptors rars used for human medicine and cosmetics
02/07/2013WO2012104865A8 N, n - dialkyl - morpholin - 4 - carboxamide compounds as insect repelling agents and a process for their preparation
02/06/2013EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
02/05/2013US8367822 Compositions and methods for bone formation and remodeling
02/05/2013US8367661 Heterocyclic sulfonamides
02/05/2013US8367660 Modulators of cystic fibrosis transmembrane conductance regulator
02/05/2013CA2492273C 3, 10, and 12a substituted tetracycline compounds
01/2013
01/31/2013WO2010133724A3 Halogenated derivatives of 2h-1,4-benzoxazin-3(4h)-one with c-2 alkyl chains or n-4 acyl residues
01/31/2013US20130029991 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
01/31/2013US20130029979 Fused bicyclic compound
01/31/2013US20130028887 Phenylacetic acid compound
01/31/2013US20130028879 Method for controlling particular insect pests by applying anthranilamide compounds
01/30/2013CN102898397A Synthesis method of (4aR,10bR)-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazine-9-ol substance and hydrochloride thereof
01/30/2013CN102898396A Method for preparing 3-(4-fluorophenyl)-4-benzyl-2-molindone
01/23/2013CN102887872A Method for preparing amorolfine hydrochloride
01/23/2013CN101809006B Method of producing benzoxazinone-based compound
01/22/2013US8357797 Process of making 3-phenylimino-3H-phenoxazine mediator
01/22/2013CA2672271C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
01/17/2013WO2013007371A2 Kinetic resolution of chiral amines
01/15/2013US8354403 Pyrrolidine derived beta 3 adrenergic receptor agonists
01/10/2013US20130012702 Purification of progesterone receptor modulators
01/10/2013US20130012701 Quaternary heteroatom containing compounds
01/09/2013CN102863399A Synthetic method for isatoic anhydride derivative
01/08/2013CA2628921C Process for the preparation of delmopinol and derivatives thereof
01/03/2013WO2013000651A1 Fluorinated arylalkylaminocarboxamide derivatives
01/03/2013CA2833824A1 Fluorinated arylalkylaminocarboxamide derivatives
01/02/2013EP2539316A1 Latent acids and their use
01/02/2013CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion
01/01/2013US8343972 Organic compounds
12/2012
12/27/2012US20120329787 Fungicidal pyranones and oxazinones
12/26/2012CN102844309A Processes for the preparation of rivaroxaban and intermediates thereof
12/25/2012US8338442 Remedies for psychoneurosis
12/20/2012WO2012110833A3 Fluorescence modulators
12/20/2012US20120323004 Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof
12/20/2012US20120322717 Compounds and assays for controlling Wnt activity
12/19/2012CN102834384A Oxazine derivative
12/19/2012CN102827097A Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
12/19/2012CN102827096A Synthesis of naphthoxazinone derivatives through functional ionic liquid solvent-free catalysis
12/19/2012CN102827095A Benzoxazine resin mid-body containing arylamine and preparation method thereof
12/19/2012CN102827094A 2,3,6(8)-tri-substituted-3,4-dihydro-2H-1,3-benzoxazines compound
12/18/2012CA2536576C Derivatives of hydroxamic acid as metalloproteinase inhibitors
12/13/2012WO2012168265A1 Substituted benzamide derivatives
12/13/2012US20120316173 Compounds which modulate the cb2 receptor
12/13/2012CA2834675A1 Substituted benzamide derivatives
12/12/2012CN102816127A Double-terminal group phthalonitrile-benzoxazine resin intermediate and its synthesis method
12/12/2012CN102816109A Method for synthesizing Hantzsch ester
12/11/2012US8329897 Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
12/11/2012US8329690 Cyclothiocarbamate derivatives as progesterone receptor modulators
12/11/2012CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
12/05/2012CN101857548B Two-aromatic amino terminated dianthracene compound, preparation method and application thereof
12/04/2012US8324430 Processes for preparing amines and catalysts for use therein
11/2012
11/29/2012WO2012160392A1 Morpholino compounds, uses and methods
11/29/2012US20120302549 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
11/28/2012CN102796057A Bis-benzoxazinone compound and preparation method thereof
11/28/2012CN101636391B Novel prophylactic and/or therapeutic agent for neurogenic pain
11/27/2012US8318982 Catalyst and process for preparing an amine
11/27/2012US8318930 Process for preparing polymorphic forms of (S)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318729 Phenylacetic acid compound
11/27/2012US8318706 Substituted tetracycline compounds
11/22/2012WO2012156284A1 1,3-oxazines as bace1 and/or bace2 inhibitors
11/22/2012US20120295910 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012CA2832384A1 1,3-oxazines as bace1 and/or bace2 inhibitors
11/20/2012US8314233 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
11/20/2012US8314094 Benzoxazinone derivative
11/20/2012CA2693180C Fused bicyclic compound
11/20/2012CA2482466C Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
11/15/2012WO2012154760A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012WO2012154204A1 Hydroxamic acid derivatives and their use in the treatment of bacterial infections
11/15/2012WO2012128582A3 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012CA2834164A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012CA2817211A1 Hydroxamic acid derivatives and their use in the treatment of bacterial infections
11/14/2012EP2522670A1 Heterocyclic CRF receptor antagonists
11/14/2012EP2521717A1 Method for the preparation of rivaroxaban
11/14/2012CN102781911A Latent acids and their use
11/14/2012CN101321730B Cyclopropyl amines as modulators of the histamine H3 receptor
11/13/2012US8309715 Camphor-derived β-amino alcohol compounds, method for manufacturing the same and asymmetric addition of organozinc to aldehydes using the same
11/13/2012US8309597 1,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use
11/07/2012CN101228141B Tetrahydrobenzoxazines as stabilisers
11/07/2012CN101024633B Tricyclic arylamine monomer and polymers and devices thereof
11/06/2012US8304538 Method of producing benzoxazinone-based compound
11/06/2012US8304537 Use of oxazine compounds for making chromogenic materials
11/01/2012WO2012146692A1 Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
10/2012
10/31/2012EP2518059A1 4-amino-1,3-thiazine or oxazine derivative
10/31/2012EP2516392A1 Substituted benzamide derivatives
10/31/2012CN1768149B Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives
10/30/2012US8299244 Melamine compound and method for manufacturing the same
10/30/2012US8299075 Substituted thiomorpholine derivatives
10/30/2012US8299065 Antibacterial condensed thiazoles
10/30/2012US8299063 Amido-thiophene compounds and their use
10/30/2012US8298453 Photochromic material
10/25/2012US20120271047 Novel Polymorphs of Efavirenz
10/25/2012US20120270863 Fused ring analogues of anti-fibrotic agents
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 112